ALANNA IORIO: Open Payments
NPI 1295556256 · SAN MARCOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,421 in 204 payments from 48 companies in 2025. Trend: 2023 $117 · 2024 $1,964 · 2025 $6,421
Food & beverage: $5,923Education: $498
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 29 | $996 |
| Janssen Biotech, Inc. | 15 | $713 |
| Daiichi Sankyo Inc. | 10 | $345 |
| Novartis Pharmaceuticals Corporation | 14 | $344 |
| PFIZER INC. | 12 | $341 |
| EISAI INC. | 10 | $329 |
| Merck Sharp & Dohme LLC | 9 | $233 |
| PharmaEssentia USA Corporation | 8 | $210 |
| Exelixis Inc. | 4 | $192 |
| GENZYME CORPORATION | 7 | $189 |
Products named: Lenvima, RYBREVANT, ELREXFIO, Enhertu, TECVAYLI, KEYTRUDA, BESREMI, MI CANCER SEEK.
Industry payments across CA — which companies pay providers there.
